Aster Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26 Buy
+1
New +$28 ﹤0.01% 956
2025
Q4
– Sell
-234
Closed -$3.18K – 1367
2025
Q3
$3.18K Buy
+234
New +$2.43K ﹤0.01% 845
2025
Q1
– Sell
-192
Closed -$2.86K – 1605
2024
Q4
$2.86K Buy
+192
New +$3.14K ﹤0.01% 928

Other funds holding RCUS

Aster Capital Management's RCUS Position: Q3 2026 in Review

Aster Capital Management opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 1 share worth $26. The stake represents ﹤0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RCUS as recently as Q3 2025.

Aster Capital Management first reported a position in RCUS in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.18K in Q3 2025. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Aster Capital Management held 1 share of Arcus Biosciences worth $26 as of Q3 2026.
  • Arcus Biosciences was a new Aster Capital Management position in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #956 holding.
  • Aster Capital Management first reported a position in Arcus Biosciences in Q4 2024 and has held it in 3 quarters since.
  • Aster Capital Management's Arcus Biosciences position peaked at $3.18K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.